XML 63 R46.htm IDEA: XBRL DOCUMENT v3.20.4
Subsequent Events (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Jan. 15, 2021
Dec. 30, 2019
Jan. 31, 2021
Mar. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Subsequent Event [Line Items]                
Proceeds from related party debt financing             $ 200,000 $ 113,700
Options granted (in shares)             1,679,338  
Share-based compensation         $ 7,010 $ 19,795 $ 21,746 $ 34,178
Former Chief Executive Officer | Forecast                
Subsequent Event [Line Items]                
Severance       $ 1,900        
Share-based compensation       $ 28,000        
Subsequent Event | Principal Executive Officer                
Subsequent Event [Line Items]                
Options granted (in shares)     306,427          
Subsequent Event | Principal Executive Officer | Restricted stock units (unvested)                
Subsequent Event [Line Items]                
Awards granted (in shares)     223,076          
Annual vesting percentage 25.00%              
Quarterly vesting percentage 6.25%              
Subsequent Event | Principal Executive Officer | Stock Options                
Subsequent Event [Line Items]                
Annual vesting percentage 25.00%              
Quarterly vesting percentage 6.25%              
Letter Agreement with Sumitomo Dainippon Pharma, Co., Ltd. | Term Loan                
Subsequent Event [Line Items]                
Proceeds from related party debt financing   $ 113,700            
Sumitomo Dainippon Pharma Co., Ltd. | Letter Agreement with Sumitomo Dainippon Pharma, Co., Ltd. | Term Loan | Majority Shareholder | Subsequent Event                
Subsequent Event [Line Items]                
Proceeds from related party debt financing     $ 45,000          
Available borrowing capacity     $ 41,300